Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
In TRIUMPH-3, both studied doses of retatrutide (9 mg and 12 mg) delivered substantial weight loss in adults with severe obesity and established cardiovascular disease, with or without type 2 diabetes
A 38-week phase 3 trial comparing the effects of KarXT (NCT05511363) and placebo in participants with psychosis associated with AD dementia was started in August 2022
Enjoy one as a post-workout snack at the gym or take it on a hike to enhance your nutrition on-the-go
These numbers require context
We ensure your order is handled with the utmost discretion and shipped promptly to your Jacksonville lab, packaged to maintain stability and integrity during transit
Albumin affibody-outfitted injectable gel enabling extended release of urate oxidase-albumin conjugates for hyperuricemia treatment
